Drug

Peptidoglycan Complex of Spirulina K-001 clinical trials

studies test it: 3
open now: 0
in phase 3: 1
first study started: 2016

How studies write it

Studies that test it under each name

Name

K-001: 3

Studies by the year they started

3 studies that test it; most in 2016 (1)

Studies that test Peptidoglycan Complex of Spirulina K-001, by start year
Year	Studies
2016	1
2017	1
2023	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 1
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Pancreatic Neoplasms: 2

Who runs them

Industry 1 · Other 2

Kowa Research Institute, Inc. (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · RenJi Hospital (1)

Often tested with

Tested in the same studies.

K-877 (1) · Tofogliflozin (1)

Studies

Open first, then newest update. How each study uses Peptidoglycan Complex of Spirulina K-001 is read from its arms, and is right about nine times in ten.

Testing it · 3

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452CompletedPhase 1Kowa Research Institute, Inc.NCT05722262Written as K-001
The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic CancerStatus unknownPhase 2/3RenJi HospitalNCT04183478Written as K-001
K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's TolerabilityCompletedPhase 1Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT02720666Written as K-001